Drug Enforcement D-0303-2025

Lack of Assurance of Sterility

Status

Ongoing

Classification

Class II

Report Date

April 2, 2025

Termination Date

Product Information

Product description
8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4
Product quantity
103,950 vials
Reason for recall
Lack of Assurance of Sterility
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide

Location & Firm

Recalling firm
Exela Pharma Sciences LLC
Address
1245 Blowing Rock Blvd, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0303-2025
Event ID
96481
Recall initiation date
March 7, 2025
Center classification date
March 27, 2025
Code info
Lots: 10006417 and 10006418, Exp. 11/30/2026
More code info